PRP vs. Stem Cells: 3 Key Differences That Determine Which You Need

Platelet-rich plasma therapy and stem cell therapy differ in 3 clinically meaningful ways: the source of the biological material, the complexity of the repair signal delivered, and the conditions and severity levels where each is most appropriate.

Difference 1: Source (Autologous vs. Allogeneic)

PRP uses the patient's own blood. Centrifugation concentrates the patient's own platelets, which release the patient's own growth factors at the treatment site. There is no external biological material. PRP is 100% autologous.

Stem cell therapy at Rebuild Regen uses DayZero™ umbilical cord-derived MSCs from ZEO ScientifiX: an allogeneic (donor) source from AABB-accredited, cGMP-processed perinatal tissue. The cells come from healthy, consenting donors. This is not fetal tissue.

The autologous advantage of PRP is the absence of any donor-related immune considerations. The allogeneic advantage of DayZero™ is that young perinatal MSCs produce a richer, more potent paracrine signal than the patient's own aging platelets.

Difference 2: Signaling Complexity

PRP delivers 6 primary growth factors: PDGF, TGF-beta, VEGF, EGF, IGF-1, and FGF. These are powerful repair signals, but they represent a relatively limited biological signal compared to what MSCs deliver.

DayZero™ MSCs produce a comprehensive paracrine cascade including the same growth factors, plus hundreds of micro-RNA sequences via exosomes, anti-inflammatory cytokine modulation, immunomodulatory signaling, and sustained paracrine activity that continues as long as the MSCs remain active at the treatment site.

The practical difference: stem cells provide a broader, more sustained, and more complex repair environment than PRP.

Difference 3: Appropriate Conditions and Severity Levels

PRP is the appropriate first-line regenerative therapy for mild to moderate orthopedic conditions: early-to-moderate tendinopathy, mild-moderate joint OA, hair restoration, and acute sports injuries with incomplete healing.

DayZero™ stem cells are appropriate for moderate-to-advanced conditions: moderate-severe knee OA with documented cartilage loss, prior PRP non-response, systemic inflammatory conditions, and neurological conditions where the complexity of the MSC paracrine signal is clinically indicated.

How to Know Which You Need

The clinical consultation with Elizabeth Celestin, APRN, FNP-C at Rebuild Regen Medical Clinic at 3320 N Federal Hwy #101, Lighthouse Point, FL determines which is appropriate for your specific situation. Condition type, severity on imaging, treatment history, and clinical goals all factor into the recommendation. This is not a upsell decision; it is a clinical one.

All stem cell protocols require physician supervision by [MD_PLACEHOLDER] MD under Florida SB 1768. All DayZero™ stem cell therapies are not FDA-approved and are not intended to diagnose, treat, cure, or prevent any disease.